Tixagevimab-cilgavimab reduced risk for severe COVID-19 progression in patients with hematologic malignancies on anti-CD20 therapy during the early Omicron era.

Immune checkpoint inhibitors for patients with cancer may be associated with an increased risk for psoriasis when compared ...

Celonic Group, a “Pure Play” biologics contract development and manufacturing organization (CDMO), has signed a multi-year ...

Holdings announced its plans to advance the development of its proprietary Antibody Drug Conjugate (ADC) platform ...

Lupus can do irreversible harm to a person's organs, damaging the lungs, kidneys, heart, liver and other vital organs through ...

Dr. Lin holds a Ph.D. in Molecular Pharmacology from the University of California, San Francisco, and has held leadership roles at Innovent Biologics, NGM Biopharmaceuticals, and Genentech. A ...

Biopharmaceutical CMO Market Rapid outsourcing trends and robust investments in advanced manufacturing drive the biopharmaceutical CMO mark ...

Lupus can do irreversible harm to a person’s organs, damaging the lungs, kidneys, heart, liver and other vital organs through ...

The Global Cancer Immunotherapy Market achieved a valuation of $121.2 Billion in 2023 and is anticipated to exceed $245.37 ...

If policymakers fail to act swiftly to restore medical research funding, then it’s up to those of us in the industry with the ...

Meta Platforms has unveiled plans for Project Waterworth, an ambitious initiative to construct the world's longest undersea internet cable. Spanning over 50,000 kilometers, this subsea network aims to ...

The Recombinant DNA Technology Market size is expected to be worth around USD 1288.5 Bn by 2032 from USD 786.7 Bn in 2023, growing at a CAGR of 5.8% As scientific and technological advancements ...